PCR-restriction fragment length polymorphism method to detect the X/Y polymorphism in the promoter site of the mannose-binding lectin gene [5]

Clinical Chemistry

Volumn 49, Issue 9, 2003, Pages 1557-1558

  Roelofs, Rian W ^a   Sprong, Tom ^a   De Kok, Jacques B ^a   Swinkels, Dorine W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; MANNOSE BINDING LECTIN; UNCLASSIFIED DRUG;

GENE; GENE MUTATION; HUMAN; LETTER; MBL GENE; OPSONIZATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

HUMANS; MANNOSE-BINDING LECTIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS);

EID: 0041441079     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.9.1557     Document Type: Letter

References (5)

1. Turner MW. Mannose-binding lectin (MBL) in health and disease [Review]. Immunobiology 1998;199:327-39.
2. Madsen HO, Videm V, Svejgaard A, Svennevig JL. Garred P. Association of mannose-binding-lectin deficiency with severe atherosclerosis [Letter]. Lancet 1998;352:959-60.
3. Madsen HO, Garred P, Thiel S, Kurtzhals J, Lamm LU, Ryder LP, et al. A Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013-20.
4. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998;161:3169-75.
5. Turner MW, Dinan L, Heatley S, Jack DL, Boettcher B, Lester S, et al. Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians. Hum Mol Genet 2000;9:1481-6.